NCT06542367

Brief Summary

Eligible participants with chronic tympanic membrane perforation (\>6 month) will be given a detailed description and offered to participate in the study. the study investigates the efficacy of trans canal tympanoplasty with local anesthesia using fat pad and "Tachosil". Participants will be followed for 1 year after the procedure with otological examination and successive hearing evaluations.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Sep 2024

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Sep 2024Sep 2026

First Submitted

Initial submission to the registry

August 1, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
25 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

1.5 years

First QC Date

August 1, 2024

Last Update Submit

August 12, 2024

Conditions

Keywords

Tympanoplasty

Outcome Measures

Primary Outcomes (1)

  • closure of tympanic membrane perforation

    the effectiveness of the tympanoplasty using far graft and "Tachosil" will be evaluated - whether close of tympanic membrane perforation occured.

    1 year following the procedure

Secondary Outcomes (3)

  • Hearing results following tympanoplasty - Speech recognition threshold

    1 year following the procedure

  • Hearing results following tympanoplasty - Pure Tone Average

    1 year following the procedure

  • Hearing results following tympanoplasty - air bone gap.

    1 year following the procedure

Study Arms (1)

Transcanal tympanoplasty under local anasthesia with fat graft and "Tachosil"

EXPERIMENTAL

eligibale participatns with chronic tympanic membrane perforation will be offered to participate. Under local anesthesia, subcutaneous fat from the neck will be harvested. After that trimming of the perforation edges, planting the fat graft medial to the tympanic membrane and placement of the "Tachosil" on top of the fat graft. gelfoam is placed lateral to the tympanic membrane fo fill the ear canal. follow-up will be held at 2, 4-6 and 12 month following the procedure, with audiometric and otological evaluation

Procedure: Tympanoplasty performed under local anesthesia using fat graft and "Tachosil".

Interventions

Under local anesthesia, subcutaneous fat from the neck will be harvested. After that trimming of the perforation edges, planting the fat graft medial to the tympanic membrane and placement of the "Tachosil" on top of the fat graft. gelfoam is placed lateral to the tympanic membrane to fill the ear canal. follow-up will be held at 2, 4-6 and 12 months following the procedure, with audiometric and otological evaluation

Transcanal tympanoplasty under local anasthesia with fat graft and "Tachosil"

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic tympanic membrane perforation (\>6 months).
  • Central tympanic membrane perforation.
  • Air bone gar of 35 dB or lower at the operated ear.
  • No active otorrhea in the operated ear in the preceding 3 month prior to the procedure.
  • No evidence of a retraction pocket and no suspicion for a cholesteatoma.

You may not qualify if:

  • Known ossicular chain dysfunction
  • The tympanic membrane perforation edges are not accessible/visualized transcanal
  • Pregnancy
  • Allergy to lidocaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Tympanic Membrane Perforation

Interventions

TachoSil

Condition Hierarchy (Ancestors)

Ear DiseasesOtorhinolaryngologic DiseasesWounds and Injuries

Central Study Contacts

yoni Evgeni Gutkovich, M.D/Ph.D

CONTACT

Lev Shlizerman, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 1, 2024

First Posted

August 7, 2024

Study Start

September 1, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

August 13, 2024

Record last verified: 2024-08